Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, View ORCID ProfileEugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
doi: https://doi.org/10.1101/2021.08.03.21261496
Ariel Israel
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
M.D., Ph.D.Eugene Merzon
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Alejandro A. Schäffer
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
Ph.D.Yotam Shenhar
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
Ph.D.Ilan Green
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Avivit Golan-Cohen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D.Eytan Ruppin
2Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD USA
M.D., Ph.DEli Magen
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
4Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
M.D., Ph.D.Shlomo Vinker
1Leumit Research Institute & Department of Family Medicine, Leumit Health Services, Israel
3Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
M.D., M.H.A.Data Availability
Data were obtained from patients' electronic health records, and IRB approval restrains its use to researchers inside Leumit Health Services.
Posted August 05, 2021.
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
medRxiv 2021.08.03.21261496; doi: https://doi.org/10.1101/2021.08.03.21261496
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, Yotam Shenhar, Ilan Green, Avivit Golan-Cohen, Eytan Ruppin, Eli Magen, Shlomo Vinker
medRxiv 2021.08.03.21261496; doi: https://doi.org/10.1101/2021.08.03.21261496
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (682)
- Anesthesia (182)
- Cardiovascular Medicine (2719)
- Dermatology (233)
- Emergency Medicine (410)
- Epidemiology (12362)
- Forensic Medicine (10)
- Gastroenterology (781)
- Genetic and Genomic Medicine (4214)
- Geriatric Medicine (394)
- Health Economics (696)
- Health Informatics (2722)
- Health Policy (1012)
- Hematology (369)
- HIV/AIDS (872)
- Medical Education (403)
- Medical Ethics (111)
- Nephrology (449)
- Neurology (3997)
- Nursing (216)
- Nutrition (592)
- Oncology (2104)
- Ophthalmology (600)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1141)
- Primary Care Research (464)
- Public and Global Health (6620)
- Radiology and Imaging (1435)
- Respiratory Medicine (881)
- Rheumatology (417)
- Sports Medicine (350)
- Surgery (458)
- Toxicology (57)
- Transplantation (192)
- Urology (171)